ABCD1 dysfunction alters white matter microvascular perfusion

X-linked adrenoleukodystrophy is a neurodegenerative disorder caused by mutations in ABCD1. By applying a vascular model to conventional MR perfusion imaging, Lauer et al. demonstrate that ABCD1 deficiency causes alterations in microvascular flow in white matter areas and developmental stages with the highest probability for conversion to cerebral disease.

[1]  Kim Mouridsen,et al.  Reliable estimation of microvascular flow patterns in patients with disrupted blood–brain barrier using dynamic susceptibility contrast MRI , 2017, Journal of magnetic resonance imaging : JMRI.

[2]  B. Thomas,et al.  Combining Diffusion Tensor Metrics and DSC Perfusion Imaging: Can It Improve the Diagnostic Accuracy in Differentiating Tumefactive Demyelination from High-Grade Glioma? , 2017, American Journal of Neuroradiology.

[3]  L. Prosser,et al.  Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation , 2016, Genetics in Medicine.

[4]  R. Wanders,et al.  Adrenoleukodystrophy – neuroendocrine pathogenesis and redefinition of natural history , 2016, Nature Reviews Endocrinology.

[5]  G. Raymond,et al.  Childhood Cerebral Adrenoleukodystrophy: MR Perfusion Measurements and Their Use in Predicting Clinical Outcome after Hematopoietic Stem Cell Transplantation , 2016, American Journal of Neuroradiology.

[6]  D. Reich,et al.  Advanced MRI and staging of multiple sclerosis lesions , 2016, Nature Reviews Neurology.

[7]  Thomas Dierks,et al.  Microstructure and Cerebral Blood Flow within White Matter of the Human Brain: A TBSS Analysis , 2016, PloS one.

[8]  G. Raymond,et al.  Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients , 2016, American Journal of Neuroradiology.

[9]  M. Sanson,et al.  Dramatic worsening of adult-onset X-linked adrenoleukodystrophy after head trauma , 2015, Neurology.

[10]  A. Moser,et al.  Brain endothelial dysfunction in cerebral adrenoleukodystrophy. , 2015, Brain : a journal of neurology.

[11]  P. Aubourg.  Cerebral adrenoleukodystrophy: a demyelinating disease that leaves the door wide open. , 2015, Brain : a journal of neurology.

[12]  Jette L. Frederiksen,et al.  Permeability of the blood–brain barrier predicts conversion from optic neuritis to multiple sclerosis , 2015, Brain : a journal of neurology.

[13]  G. Nagels,et al.  Cerebral Hypoperfusion: A New Pathophysiologic Concept in Multiple Sclerosis? , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  Leif Østergaard,et al.  The Effects of Transit Time Heterogeneity on Brain Oxygenation during Rest and Functional Activation , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  Kim Mouridsen,et al.  Reliable Estimation of Capillary Transit Time Distributions Using DSC-MRI , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  P. Hof,et al.  Metabolic costs and evolutionary implications of human brain development , 2014, Proceedings of the National Academy of Sciences.

[17]  Brian Hansen,et al.  Capillary transit time heterogeneity and flow-metabolism coupling after traumatic brain injury , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  Luke Macyszyn,et al.  Pattern analysis of dynamic susceptibility contrast-enhanced MR imaging demonstrates peritumoral tissue heterogeneity. , 2014, Radiology.

[19]  F. Eichler,et al.  Pathophysiology of X-linked adrenoleukodystrophy☆ , 2014, Biochimie.

[20]  L. Ngo,et al.  Hyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndrome. , 2013, Brain : a journal of neurology.

[21]  F. Eichler,et al.  Hypoperfusion predicts lesion progression in cerebral X-linked adrenoleukodystrophy. , 2012, Brain : a journal of neurology.

[22]  Leif Østergaard,et al.  The roles of cerebral blood flow, capillary transit time heterogeneity, and oxygen tension in brain oxygenation and metabolism , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  Kim Mouridsen,et al.  T1- and T*2-Dominant Extravasation Correction in DSC-MRI: Part I—Theoretical Considerations and Implications for Assessment of Tumor Hemodynamic Properties , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  Nikos Paragios,et al.  DRAMMS: Deformable Registration via Attribute Matching and Mutual-Saliency Weighting , 2009, IPMI.

[25]  Tracy T Batchelor,et al.  T1- and T2*-Dominant Extravasation Correction in DSC-MRI: Part II—Predicting Patient Outcome after a Single Dose of Cediranib in Recurrent Glioblastoma Patients , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  F. Barkhof,et al.  Correlating Quantitative MR Imaging with Histopathology in X-Linked Adrenoleukodystrophy , 2011, American Journal of Neuroradiology.

[27]  W. Brown,et al.  Review: Cerebral microvascular pathology in ageing and neurodegeneration , 2011, Neuropathology and applied neurobiology.

[28]  Brian B. Avants,et al.  N4ITK: Improved N3 Bias Correction , 2010, IEEE Transactions on Medical Imaging.

[29]  G. Raymond,et al.  Head trauma can initiate the onset of adreno-leukodystrophy , 2010, Journal of the Neurological Sciences.

[30]  P. Szwarc.  Segmentation of Brain Tumours in MR Images , 2009 .

[31]  Elfar Adalsteinsson,et al.  Seven-Tesla proton magnetic resonance spectroscopic imaging in adult X-linked adrenoleukodystrophy. , 2008, Archives of neurology.

[32]  F. Villarroya,et al.  Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy. , 2008, Human molecular genetics.

[33]  A. Moser,et al.  Is microglial apoptosis an early pathogenic change in cerebral X‐linked adrenoleukodystrophy? , 2008, Annals of neurology.

[34]  G. Johnson,et al.  Perfusion Magnetic Resonance Imaging Correlates of Neuropsychological Impairment in Multiple Sclerosis , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  H. Moser,et al.  Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study , 2007, The Lancet Neurology.

[36]  B. Ances,et al.  Baló's concentric sclerosis presenting as a stroke-like syndrome , 2007, Nature Clinical Practice Neurology.

[37]  H. Moser,et al.  Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy. , 2007, Archives of neurology.

[38]  Karl J. Friston,et al.  Bayesian estimation of cerebral perfusion using a physiological model of microvasculature , 2006, NeuroImage.

[39]  Y. W. Chen,et al.  Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy , 2006, Neurology.

[40]  G. Plant,et al.  Cerebral Amyloid Angiopathy , 2006 .

[41]  H. Moser,et al.  Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil. , 2005, Archives of neurology.

[42]  Andrew M Blamire,et al.  MRI Reveals That Early Changes in Cerebral Blood Volume Precede Blood–Brain Barrier Breakdown and Overt Pathology in MS-like Lesions in Rat Brain , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[43]  J. Mandel,et al.  Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. , 2004, Human molecular genetics.

[44]  J. Kira,et al.  Therapeutic effects of normal cells on ABCD1 deficient cells in vitro and hematopoietic cell transplantation in the X-ALD mouse model , 2004, Journal of the Neurological Sciences.

[45]  Frauke Zipp,et al.  Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. , 2004, Brain : a journal of neurology.

[46]  H. Moser,et al.  Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy , 2003, Neurology.

[47]  Shahin Rafii,et al.  Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration , 2003, Nature Medicine.

[48]  H. Moser,et al.  Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy , 2002, Neurology.

[49]  H. Moser,et al.  Evolution of phenotypes in adult male patients with X‐linked adrenoleukodystrophy , 2001, Annals of neurology.

[50]  G. Schmid-Schönbein,et al.  Mechanisms for cell activation and its consequences for biorheology and microcirculation: Multi-organ failure in shock. , 2001, Biorheology.

[51]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[52]  H. Moser,et al.  X-Linked Adrenoleukodystrophy: Overview and Prognosis as a Function of Age and Brain Magnetic Resonance Imaging Abnormality. A Study Involving 372 Patients , 2000, Neuropediatrics.

[53]  E. Ralston,et al.  Expression of the Adrenoleukodystrophy Protein in the Human and Mouse Central Nervous System , 1997, Neurobiology of Disease.

[54]  K. Nave,et al.  Targeted inactivation of the X‐linked adrenoleukodystrophy gene in mice , 1997, Journal of neuroscience research.

[55]  H. Moser,et al.  A mouse model for X-linked adrenoleukodystrophy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Mandel,et al.  Adrénoleucodystrophie liée à l'X , 2007 .

[57]  J. Frahm,et al.  Arrested cerebral adrenoleukodystrophy: a clinical and proton magnetic resonance spectroscopy study in three patients. , 1996, Pediatric neurology.

[58]  H. Moser,et al.  Adrenoleukodystrophy: a scoring method for brain MR observations. , 1994, AJNR. American journal of neuroradiology.

[59]  Jean Mosser,et al.  Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters , 1993, Nature.

[60]  M. A. Bell,et al.  Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. , 1990, AJNR. American journal of neuroradiology.

[61]  E. M. Renkin,et al.  B. W. Zweifach Award lecture. Regulation of the microcirculation. , 1985, Microvascular research.

[62]  K Suzuki,et al.  Adrenoleukodystrophy. A clinical and pathological study of 17 cases. , 1975, Archives of neurology.